SYRE
USDSpyre Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$21.880
High
$22.540
Low
$21.150
Volume
0.80M
Company Fundamentals
Market Cap
1.7B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.83M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Reported positive interim Phase 1 results for SPY003, a next-generation anti-IL-23 antibody, demonstrating the molecule was well-tolerated and exhibited an ~85-day half-life supporting quarterly or twice annual
Spyre Therapeutics to Participate in Upcoming November Investor Conferences
WALTHAM, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
WALTHAM, Mass., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ:SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of
Related Stocks
FTAIP
FTAI Aviation Ltd. 8.25% Fixed to Floating Rate Series A Cumulative Perpetual Redeemable Preferred Shares
BSET
Bassett Furniture Industries Incorporated
OBIO
Orchestra BioMed Holdings Inc. Ordinary Shares
BLKB
Blackbaud Inc.
AVY
Avery Dennison Corporation
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.